Search Results - "Létourneau, Richard"
-
1
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study
Published in The lancet oncology (01-03-2011)“…Summary Background Axitinib is a potent, selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2, and 3. A randomised phase 2 trial of…”
Get full text
Journal Article -
2
Efficacy of gemcitabine plus axitinib compared with gemcitabine alone in patients with advanced pancreatic cancer: an open-label randomised phase II study
Published in The Lancet (British edition) (21-06-2008)“…Summary Background Axitinib (AG-013736) is a potent and selective oral inhibitor of vascular endothelial growth factor receptors 1, 2, and 3, which have an…”
Get full text
Journal Article -
3
Prognostic value of CD73 expression in resected colorectal cancer liver metastasis
Published in Oncoimmunology (01-01-2020)“…Immune checkpoint blockade has not yet been effective in patients with mismatch repair proficient metastatic colorectal cancer. Targeting immunosuppressive…”
Get full text
Journal Article -
4
Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns
Published in British journal of cancer (18-05-2022)“…Background After resection, colorectal cancer liver metastases (CRLM) surrounded by a desmoplastic rim carry a better prognosis than the metastases replacing…”
Get full text
Journal Article -
5
Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy
Published in Oncoimmunology (31-12-2023)“…In colorectal cancer liver metastases (CRLM), the density of tumor-infiltrating lymphocytes, the expression of class I major histocompatibility complex…”
Get full text
Journal Article -
6
Effect of intraoperative hypovolemic phlebotomy on transfusion and clinical outcomes in patients undergoing hepatectomy: a retrospective cohort study
Published in Canadian journal of anesthesia (01-07-2021)“…Background There is no consensus on how to best achieve a low central venous pressure during hepatectomy for the purpose of reducing blood loss and red blood…”
Get full text
Journal Article -
7
When a Drain is the Culprit: An Unexpected Case of Small Bowel Obstruction with Biliary Peritonitis
Published in Curēus (Palo Alto, CA) (21-06-2019)“…Although postoperative abdominal drains are useful in therapeutic settings, their prophylactic role is debatable. We herein describe the case of a 30-year-old…”
Get full text
Journal Article -
8
Portal vein embolization does not affect the long-term survival and risk of cancer recurrence among colorectal liver metastases patients: A prospective cohort study
Published in International journal of surgery (London, England) (01-01-2019)“…Previous studies comparing the survival outcomes of liver resections with and without preoperative portal vein embolization (PVE) for colorectal liver…”
Get full text
Journal Article -
9
Is intra-operative ultrasound still useful for the detection of a hepatic tumour in the era of modern pre-operative imaging?
Published in HPB (Oxford, England) (01-09-2011)“…Abstract Background The current role of intra-operative ultrasound (IOUS) is questioned because of recent progress in medical imaging. The aim of the present…”
Get full text
Journal Article -
10
Hypertrophy of the non-embolized liver after chemotherapy
Published in HPB (Oxford, England) (01-03-2009)“…Neoadjuvant chemotherapy (NC+) and portal vein embolization (PVE) enables curative resection in more patients with colorectal-liver metastases (CRLM). However,…”
Get full text
Journal Article -
11
Randomized Phase III Study of Exatecan and Gemcitabine Compared With Gemcitabine Alone in Untreated Advanced Pancreatic Cancer
Published in Journal of clinical oncology (20-09-2006)“…Exatecan mesylate is a hexacyclic, water-soluble, topoisomerase-1 inhibitor. Exatecan has single-agent and combination activity with gemcitabine in advanced…”
Get full text
Journal Article -
12
Outcomes of Older Patients with Resectable Colorectal Liver Metastases Cancer (CRLM): Single Center Experience
Published in Current oncology (Toronto) (18-05-2021)“…Surgery is the only potential curative option of CRLM if resectable. The curative approach in patients over 70 years old is challenging mainly because of…”
Get full text
Journal Article -
13
IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells
Published in The Journal of immunology (1950) (01-11-2003)“…Fc epsilon RI cross-linkage in mast cells results in release of granule-associated mediators, such as histamine and proteases, as well as the production of…”
Get full text
Journal Article -
14
Gastrointestinal stromal tumours: etiology, pathology and clinical management
Published in Canadian journal of gastroenterology (01-09-2004)“…Investigation of the regulation of cell growth, differentiation and death by signalling pathways has led to a greater understanding of how alterations in these…”
Get full text
Journal Article -
15
Corticotropin-Releasing Hormone Induces Skin Mast Cell Degranulation and Increased Vascular Permeability, A Possible Explanation for Its Proinflammatory Effects
Published in Endocrinology (Philadelphia) (01-01-1998)“…Abstract Mast cells are involved in atopic disorders, often exacerbated by stress, and are located perivascularly close to sympathetic and sensory nerve…”
Get full text
Journal Article -
16
Transjugular intrahepatic portosystemic shunt before abdominal surgery in cirrhotic patients: a retrospective, comparative study
Published in Canadian journal of gastroenterology (01-06-2006)“…Surgery in cirrhotic patients is associated with high morbidity and mortality related to portal hypertension and liver insufficiency. Therefore, preoperative…”
Get full text
Journal Article -
17
Trigeminal nerve stimulation triggers oral mast cell activation and vascular permeability
Published in Annals of allergy, asthma, & immunology (2014)“…Abstract Background The nervous system contributes to the pathophysiology of allergic and inflammatory diseases, including oral inflammation. Mast cells (MCs)…”
Get full text
Journal Article -
18
Acute Immobilization Stress Triggers Skin Mast Cell Degranulation via Corticotropin Releasing Hormone, Neurotensin, and Substance P: A Link to Neurogenic Skin Disorders
Published in Brain, behavior, and immunity (01-09-1999)“…Many skin disorders, such as atopic dermatitis and psoriasis, worsen during stress and are associated with increased numbers and activation of mast cells which…”
Get full text
Journal Article -
19
Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors
Published in The Journal of pharmacology and experimental therapeutics (01-03-1999)“…Urocortin (Ucn) is related to corticotropin-releasing hormone (CRH), and both are released in the brain under stress where they stimulate CRH 1 and 2 receptors…”
Get more information
Journal Article -
20
Pentosanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: an alternative explanation of its beneficial effect in interstitial cystitis
Published in The Journal of urology (01-12-2000)“…Mast cells are ubiquitous cells derived from the bone marrow and are responsible for allergic reactions as they release numerous vasodilatory, nociceptive and…”
Get more information
Journal Article